A detection method for fingerprint spectrum of traditional Chinese medicine preparations for preventing and treating infectious rhinitis in poultry
Through the combination of HPLC fingerprint map and gray correlation analysis, the complexity of the quality control of traditional Chinese medicine preparations for preventing and treating infectious rhinitis in poultry is solved, and comprehensive quantitative detection and anti-inflammatory activity evaluation of traditional Chinese medicine preparation ingredients is achieved, simplifying the detection process and improving the detection process Test efficiency.
Patent Information
- Application Number
- CN202210912200.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-07-30
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2042-07-30
AI Technical Summary
The prior art is difficult to effectively control the quality of traditional Chinese medicine preparations for preventing and treating infectious rhinitis in poultry, especially due to their unique formulas and complex ingredients, the quantitative detection of single ingredient increases cost and time, and lacks spectral effect relationship research.
Using HPLC fingerprint detection method, the chlorogenic acid, montellin, luteolin, magnolitin and erupin were quantified by simultaneously detecting chlorogenic acid, montellin, luteolin, magnolitin and erupin, and combined with gray correlation analysis, a quality detection method based on spectral effect relationship was established and the evaluation was evaluated. The anti-inflammatory activity and quality consistency of traditional Chinese medicine preparations.
A comprehensive and accurate detection of the quality of traditional Chinese medicine preparations for preventing and treating infectious rhinitis in poultry is simple and objective, avoiding interference from human factors, shortening detection time, reducing resource consumption, and revealing monsoglycin, magnolitin and eruqianhu The correlation between biocide and anti-inflammatory effects.
Smart Images

Figure CN115184509B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of drug detection, and in particular relates to a detection method for a fingerprint spectrum of a traditional Chinese medicine preparation for preventing and treating poultry infectious rhinitis based on spectrum-effect relationship. Technical Background
[0002] The Chinese medicine preparation for preventing and treating infectious rhinitis in poultry is composed of fried Xanthium sibiricum, Plantago, Magnolia, Angelica dahurica, Buddleja bud and other medicinal materials. Fried Xanthium sibiricum is the dried mature fruit with involucre of Xanthium sibiricum, a plant of Asteraceae, which is stir-fried until yellow-brown, and has chlorogenic acid, xanthioside and other chemical components as the main chemical components, and has the effects of dispersing rheumatism, clearing the nasal passages, and relieving sores; Plantago is the dried whole herb of Plantago or Plantago asiatica, a plant of Plantaginaceae, and has caryophyllene and magnolin as the main active ingredients, and has the effects of clearing heat, promoting diuresis, cooling blood and detoxifying; Magnolia is the dried flower buds of Magnolia officinalis, Magnolia grandiflora or Magnolia wudangensis, a plant of Magnoliaceae, and has volatile oil, magnolin and flavonoids as the main active ingredients, and has anti-inflammatory and anti-allergic effects. , central nervous system inhibition, etc., and has the effects of dispersing wind and cold and clearing the nasal passages; Angelica dahurica is the root of the Umbelliferae plant Angelica dahurica and Angelica dahurica, which contains volatile oils and coumarins such as imperatorin and isoimperatorin, which have the effects of antipyretic, anti-inflammatory, and relaxing smooth muscles, and are mainly used to treat colds, nasal congestion, etc.; Buddleja buddleja is the bud and inflorescence of the Buddleja buddleja of the Loganaceae family, with flavonoids such as mongoside, buddleja new glycosides and iridoid ether terpenoids such as aucubin as the main active ingredients, and has the effects of protecting the liver, anti-inflammatory and antibacterial, antispasmodic, and antioxidant. When used in combination with other important herbs, it can effectively prevent and treat infectious rhinitis in poultry and relieve various symptoms caused by infectious rhinitis. Due to the large variety of Chinese medicinal materials, how to establish a simple and effective quality control technology to ensure the consistency of Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry is of great significance to the quality control of Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry.
[0003] As a key technology for quality control of traditional Chinese medicine, the fingerprint of traditional Chinese medicine can comprehensively reflect the overall concentration distribution of various chemical components in traditional Chinese medicine. It is a means of overall quality control of traditional Chinese medicine, and has a far-reaching impact on the improvement of traditional Chinese medicine production technology and the standardization of quality control of traditional Chinese medicine finished products. On the other hand, as a comprehensive and quantifiable identification method, at this stage, the fingerprint of traditional Chinese medicine is one of the quality control modes that conforms to the characteristics of traditional Chinese medicine, judging authenticity, evaluating quality, and examining stability and consistency by comparing the similarity of fingerprint features.
[0004] At present, due to the unique formulation and complex composition of traditional Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry, if quantitative detection of a single component is carried out, the detection cost as well as personnel and time costs in quality control will increase; and this prescription is a unique formulation, and there has been no previous research on the spectrum-effect relationship of this prescription. Therefore, the research methods for quality control of traditional Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry need to be further explored. Summary of the invention
[0005] In view of this, the present invention provides a method for detecting the fingerprint of a Chinese medicine preparation for preventing and treating infectious rhinitis in poultry, wherein the Chinese medicine components in the Chinese medicine preparation include stir-fried Xanthium sibiricum, Plantago, Magnolia officinalis, Angelica dahurica and Buddleja flos. The HPLC fingerprint detection method provided by the present invention can effectively and simultaneously quantitatively detect chlorogenic acid, mongoside, luteolin, magnolia bark and imperatorin; the detection method of the present invention has the advantages of simple method and strong objectivity, and is conducive to the quality detection of Chinese medicine preparations for preventing and treating infectious rhinitis in poultry.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] In a first aspect, the present invention provides a method for detecting a fingerprint of a Chinese medicine preparation for preventing and treating poultry infectious rhinitis, the detection method comprising the following steps:
[0008] (1) Preparation of reference solution: Weigh chlorogenic acid, montmorillonine, luteolin, magnolin and imperatorin reference substances respectively, and dilute them with methanol to prepare stock solutions; mix the stock solutions to prepare the reference solution;
[0009] (2) Preparation of test solution: accurately weigh the Chinese medicine preparation for preventing and treating poultry infectious rhinitis, add 50% methanol / water solution, weigh, sonicate, bring to room temperature, weigh again, make up for the loss, filter, and obtain the test solution;
[0010] (3) Analysis and detection: analysis was performed using high performance liquid chromatography-ultraviolet detection;
[0011] (4) Establish fingerprint: extract characteristic chromatographic peaks.
[0012] Furthermore, the preparation of the reference solution in step (1) is as follows: an appropriate amount of chlorogenic acid reference substance is taken, accurately weighed, and methanol is added to prepare a stock solution containing 500 μg of chlorogenic acid per 1 ml; an appropriate amount of leucoside reference substance is taken, accurately weighed, and methanol is added to prepare a stock solution containing 1000 μg of leucoside per 1 ml; an appropriate amount of luteolin reference substance is taken, accurately weighed, and methanol is added to prepare a stock solution containing 1000 μg of luteolin per 1 ml; an appropriate amount of magnolia bark reference substance is taken, accurately weighed, and methanol is added to prepare a stock solution containing 1000 μg of magnolia bark per 1 ml; an appropriate amount of imperatorin reference substance is taken, accurately weighed, and methanol is added to prepare a stock solution containing 100 μg of imperatorin per 1 ml.
[0013] Preparation of mixed reference substance: Mix the stock solutions and dilute with methanol to prepare a mixed reference solution with a chlorogenic acid concentration of 50 μg / ml, a montmorillonin concentration of 100 μg / ml, a luteolin concentration of 100 μg / ml, a magnolin concentration of 100 μg / ml, and an imperatorin concentration of 10 μg / ml.
[0014] Furthermore, in step (2), the preparation of the test solution is preferably as follows: accurately weigh 2 g of the Chinese medicine preparation for preventing and treating poultry infectious rhinitis and place it in a stoppered conical flask, add 25 ml of 50% methanol / water, weigh the weight, ultrasonically treat for 30 minutes, let it cool to room temperature, weigh the weight again, make up the lost weight with 50% methanol / water, shake well, and filter with a 0.45 μm microporous membrane to obtain the solution.
[0015] The HPLC chromatographic conditions in step (3) are as follows: the chromatographic column is Supfex JX-C18, 5 μm, 4.6×250 mm; the column temperature is 30° C.; the flow rate is 1.0 ml / min; the detection wavelength is 250 nm; pure acetonitrile is used as mobile phase A, and 0.1% formic acid / water is used as mobile phase B, and gradient elution is performed.
[0016] Preferably, the elution conditions are: 0-35 min, 8%-15% A; 35-75 min, 15%-30% A; 75-110 min, 30%-40% A; 110-150 min, 40%-60% A; 150-155 min, 60%-40% A.
[0017] The content of chlorogenic acid, magnoside, luteolin, magnolin and imperatorin were quantitatively detected using the external standard quantitative method.
[0018] The retention times of the characteristic chromatographic peaks extracted in step (4) are: chlorogenic acid 20.843-20.966 min, limonene 73.046-73.294 min, luteolin 76.478-76.691 min, magnolin 115.218-115.453 min, and imperatorin 134.786-134.910 min.
[0019] In a second aspect of the present invention, based on the above-mentioned HPLC fingerprint detection method of the Chinese medicine preparation for preventing and treating poultry infectious rhinitis, the present invention also provides a quality detection method of the Chinese medicine preparation for preventing and treating poultry infectious rhinitis based on spectrum-effect relationship, comprising the following steps:
[0020] (1) To establish an HPLC fingerprint detection method for Chinese herbal medicine preparations for the prevention and treatment of poultry infectious rhinitis;
[0021] (2) Determine the anti-inflammatory activity of Chinese herbal medicines for the prevention and treatment of infectious rhinitis in poultry;
[0022] (3) performing grey correlation analysis on the peak area of the characteristic peak identified in step (1) and the anti-inflammatory activity obtained in step (2), and calculating the correlation between each characteristic peak and the anti-inflammatory activity to evaluate the anti-inflammatory activity of the characteristic peak.
[0023] In the present invention, HPLC fingerprint similarity evaluation of 10 batches of Chinese medicinal preparations for preventing and treating poultry infectious rhinitis was carried out.
[0024] The present invention obtains common characteristic peaks by establishing an HPLC fingerprint of a Chinese medicinal preparation for preventing and treating infectious rhinitis in poultry; determines the anti-inflammatory factor index of the Chinese medicinal preparation for preventing and treating infectious rhinitis in poultry by establishing a cell anti-inflammatory model; then establishes a grey correlation analysis according to the peak area and anti-inflammatory index of the characteristic peak of the HPLC fingerprint, and uses the established grey correlation analysis method to evaluate the correlation between the characteristic peak and the anti-inflammatory activity.
[0025] The steps for determining the anti-inflammatory activity of the Chinese medicinal preparation for preventing and treating poultry infectious rhinitis in step (2) are as follows:
[0026] 1) Preventive anti-inflammatory test: RAW264.7 cells were placed in a 96-well plate, and after 24 hours, the sample solution of the Chinese medicine preparation for preventing and treating poultry infectious rhinitis was added for culture. After 6 hours of culture, the drug-containing culture medium was discarded, and LPS was added to induce cell inflammation. After 24 hours of induction, the NO release and IL-6 and TNF-α levels in the cell supernatant were measured.
[0027] 2) Direct anti-inflammatory test: RAW264.7 cells were placed in a 96-well plate. After 24 hours, LPS was added to induce cell inflammation. At the same time, sample solutions of Chinese herbal preparations for the prevention and treatment of poultry infectious rhinitis were added to the cells. After 24 hours, the NO release and IL-6 and TNF-α levels in the cell supernatant were measured.
[0028] The steps of grey relational analysis are as follows:
[0029] 1) The anti-inflammatory activity index of each sample is composed into a reference series, and the peak area of each characteristic peak in the fingerprint spectrum of each sample is composed into a comparison series;
[0030] 2) The reference series and the comparison series in step 1) are dimensionlessly processed by using the averaging method;
[0031] 3) calculating the correlation between each characteristic peak and the anti-inflammatory activity according to the dimensionless reference series and comparison series obtained in step 2);
[0032] 4) Sort the correlations obtained in step 3) to evaluate the anti-inflammatory activity of the characteristic peaks.
[0033] In the present invention, the calculation method of the correlation degree is:
[0034] The correlation coefficient is calculated using the following formula:
[0035]
[0036] Among them, x0(k) represents the reference sequence, x i(k) represents the comparison series, ρ is the resolution coefficient, and the ρ value is 0.5;
[0037] Then calculate the correlation according to the following formula:
[0038]
[0039] The averaging method usually refers to dividing each variable value by the average value of the variable. This method eliminates the influence of dimension and order of magnitude while retaining the information on the degree of difference in the values of individual variables and the comparability of the data.
[0040] The present invention is beneficial in that:
[0041] 1. The HPLC fingerprint of Chinese herbal preparations for preventing and treating infectious rhinitis in poultry can identify the common characteristic peaks by the retention time of the chromatographic peaks, thereby ensuring the accuracy and repeatability of the characteristic peak identification; the anti-inflammatory activity of the Chinese herbal preparations for preventing and treating infectious rhinitis in poultry can be directly predicted by the HPLC fingerprint of the Chinese herbal preparations for preventing and treating infectious rhinitis in poultry, and the quality of the Chinese herbal preparations for preventing and treating infectious rhinitis in poultry can be evaluated; and the method of combining HPLC fingerprint with mathematical model can avoid peak interference caused by human factors.
[0042] 2. A single-wavelength fingerprint quality control method was established based on HPLC-UV detection technology, which can realize fingerprint analysis and quantitative detection of multiple index components including chlorogenic acid, magnoside, luteolin, magnolin and imperatorin in one analysis. It can more comprehensively and accurately evaluate the quality of traditional Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry, realize comprehensive control of traditional Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry, and at the same time shorten the detection time to the greatest extent and reduce the consumption of resources.
[0043] 3. By adopting the method of the present invention, it is known that in the Chinese medicine preparation for preventing and treating poultry infectious rhinitis, lignoside, magnolin and imperatorin have a high correlation with reducing NO release and TNF-α level in the preventive anti-inflammatory effect, and lignoside and imperatorin have a high correlation with reducing IL-6 level in the preventive anti-inflammatory effect; chlorogenic acid, lignoside and magnolin have a high correlation with reducing NO release in the direct anti-inflammatory effect, chlorogenic acid has a high correlation with reducing IL-6 level in the direct anti-inflammatory effect, and lignoside, chlorogenic acid and imperatorin have a high correlation with TNF-α level in the direct anti-inflammatory effect. The present invention has the advantages of simple method and strong objectivity, and is conducive to quality control of Chinese medicine preparations for preventing and treating poultry infectious rhinitis. BRIEF DESCRIPTION OF THE DRAWINGS
[0044] Figure 1 HPLC fingerprints of 10 batches of Chinese herbal medicines (S1-S10) for the prevention and treatment of infectious rhinitis in poultry;
[0045] Figure 2To provide a comparative HPLC fingerprint of Chinese medicine preparations for the prevention and treatment of infectious rhinitis in poultry;
[0046] Figure 3 The results of NO release from samples (S1-S10) in the inflammation prevention test;
[0047] Figure 4 Results of IL-6 level determination in samples (S1-S10) in the inflammation prevention test;
[0048] Figure 5 Results of TNF-α level determination in samples (S1-S10) in the inflammation prevention test;
[0049] Figure 6 It is the measurement result of NO release of samples (S1-S10) in direct anti-inflammatory test;
[0050] Figure 7 The results of the IL-6 level determination of samples (S1-S10) in the direct anti-inflammatory test;
[0051] Figure 8 These are the results of the TNF-α level determination of samples (S1-S10) in the direct anti-inflammatory test. DETAILED DESCRIPTION
[0052] The technical solution of the present invention is further explained and illustrated below in conjunction with examples. The examples are limited to illustrating the present invention, but not to limiting the present invention.
[0053] The relevant information of the test materials and instruments that can be used in this test in the specific embodiments is as follows:
[0054] Instruments: Waters Alliance high performance liquid chromatograph (2695 gradient pump, Waters 2487 UV detector, autosampler, column thermostat, Empower chromatography workstation), Synergy HTX multifunctional microplate reader (BioTek, USA, UV / visible absorption light).
[0055] Reagents: acetonitrile (chromatographic grade, Sigma-Aldrich), methanol (chromatographic grade, Sigma-Aldrich), experimental water was produced by Mil-Q pure water system, and the other reagents were of analytical grade; LPS (biosharp), DMEM (gibco), fetal bovine serum (Sijiqing); PBS 10× (biosharp).
[0056] Reference substances: chlorogenic acid for content determination (content: 99.3%; batch number: 110753-201716, China Food and Drug Inspection Institute, for content determination); montmorillonine (content: 95.9%; batch number: 111528-200605, China Food and Drug Inspection Institute, for content determination); luteolin (content: 96.3%; batch number: 111520-202107, China Food and Drug Inspection Institute, for content determination); magnolin (content: 98.3%; batch number: 110882-201206, China Food and Drug Inspection Institute, for content determination), imperatorin (content: 99.9%; batch number: 110826-200511, China Food and Drug Inspection Institute, for content determination).
[0057] Cell line: RAW264.7 mouse mononuclear macrophage leukemia cells were kindly provided by Tianjin University of Traditional Chinese Medicine.
[0058] Kits: NO detection kit, mouse interleukin 6 (IL-6) ELISA kit, mouse tumor necrosis factor α (TNF-α) ELISA kit.
[0059] Example 1 Establishment of HPLC fingerprint of Chinese medicine preparation for preventing and treating infectious rhinitis in poultry
[0060] Implementation Methods
[0061] 1. Analysis conditions
[0062] Instrument: WatersAlliance high performance liquid chromatograph;
[0063] Chromatographic column: Supfex JX-C18 (250*4.6mm, 5μm);
[0064] Flow rate: 1.0 mL / min;
[0065] Column temperature: 30°C;
[0066] Injection volume: 20 μL;
[0067] Wavelength collection range: 190nm~600nm;
[0068] Wavelength: 250nm;
[0069] Mobile phase: A. acetonitrile: B. 0.1% formic acid / water (v / v);
[0070] gradient:
[0071] Time (min) Acetonitrile / %(A) 0.1% Formic acid / % (B) 0~35 8→15 92→85 35~75 15→30 85→70 75~110 30→40 70→60 110~150 40→60 60→40 150~155 60→40 40→60
[0072] 2. Preparation of reference substances: Take an appropriate amount of chlorogenic acid reference substance, accurately weigh it, and add methanol to prepare a stock solution containing 500 μg of chlorogenic acid per 1 ml; take an appropriate amount of montana glycoside reference substance, accurately weigh it, and add methanol to prepare a stock solution containing 1000 μg of montana glycoside per 1 ml; take an appropriate amount of luteolin reference substance, accurately weigh it, and add methanol to prepare a stock solution containing 1000 μg of luteolin per 1 ml; take an appropriate amount of magnolia bark reference substance, accurately weigh it, and add methanol to prepare a stock solution containing 1000 μg of magnolia bark per 1 ml; take an appropriate amount of imperatorin reference substance, accurately weigh it, and add methanol to prepare a stock solution containing 100 μg of imperatorin per 1 ml. The above stock solutions were diluted with methanol to prepare mixed reference solutions with chlorogenic acid concentrations of 50 μg / ml, magnoside concentrations of 100 μg / ml, magnolin concentrations of 100 μg / ml, imperatorin concentrations of 10 μg / ml, and isoimperatorin concentrations of 10 μg / ml.
[0073] 3. Preparation of test solution: Accurately weigh 2 g of Chinese medicine for preventing and treating infectious rhinitis in poultry, place it in a stoppered conical flask, add 25 ml of 50% methanol / water, weigh it, ultrasonically treat it for 30 minutes, let it cool to room temperature, weigh it again, make up the lost weight with 50% methanol / water, shake it well, and filter it with a 0.45 μm microporous membrane to obtain the solution.
[0074] 4. Results: The test sample contained 14.88 mg / ml of chlorogenic acid, 2.78 mg / ml of montmorillonine, 0.11 mg / ml of luteolin, 3.50 mg / ml of magnolia officinalis, and 0.27 mg / ml of imperatorin.
[0075] Example 2 Methodology Verification
[0076] 1. Instrument precision verification
[0077] According to the sample preparation method and chromatographic conditions of Example 1, a sample solution was prepared and injected six times continuously. Taking luteolin (peak 3) as the reference peak, the relative retention time (Table 1) and relative peak area value (Table 2) of the characteristic peaks (peak 1: chlorogenic acid; peak 2: leucoside; peak 3: luteolin; peak 4: magnolin; peak 5: imperatorin) and the reference peaks were investigated.
[0078] The results showed that when the same sample of the traditional Chinese medicine preparation for preventing and treating infectious rhinitis in poultry was injected six times continuously, the RSD of the relative retention time of each characteristic peak was between 0.029% and 0.191%, and the RSD of the relative peak area was between 0.415% and 0.940%, indicating that the precision of the instrument used was good.
[0079] Table 1 Relative retention time RSD (precision study)
[0080] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 3.657 1.046 1.000 0.664 0.568 2 3.657 1.046 1.000 0.664 0.568 3 3.668 1.046 1.000 0.664 0.569 4 3.664 1.046 1.000 0.664 0.569 5 3.653 1.047 1.000 0.664 0.567 6 3.671 1.046 1.000 0.664 0.568 Average 3.662 1.046 1.000 0.664 0.568 SD 0.007 0.000 0.000 0.000 0.000 RSD 0.191% 0.029% 0.000% 0.035% 0.079%
[0081] Table 2 Relative peak area RSD (precision study)
[0082] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 0.093 0.136 1.000 0.256 0.117 2 0.092 0.134 1.000 0.256 0.115 3 0.093 0.136 1.000 0.255 0.117 4 0.092 0.134 1.000 0.254 0.115 5 0.092 0.135 1.000 0.254 0.115 6 0.093 0.134 1.000 0.254 0.117 Average 0.092 0.235 1.000 0.255 0.116 SD 0.001 0.001 0.000 0.001 0.001 RSD 0.737% 0.692% 0.000% 0.415% 0.940%
[0083] 2. Repeatability verification
[0084] According to the sample preparation method and chromatographic conditions of Example 1, six test solutions were prepared for analysis. Taking luteolin (peak 3) as the reference peak, the relative retention times (Table 3) and relative peak area values (Table 4) of the characteristic peaks (peak 1: chlorogenic acid; peak 2: magnoside; peak 3: luteolin; peak 4: magnolin; peak 5: imperatorin) and the reference peaks were investigated.
[0085] The results showed that when the same sample of the traditional Chinese medicine preparation for preventing and treating infectious rhinitis in poultry was injected six times continuously, the RSD of the relative retention time of each characteristic peak was between 0.050% and 0.545%, and the RSD of the relative peak area was between 0.389% and 0.883%, indicating that this method has good repeatability.
[0086] Table 3 Relative retention time RSD (repeatability study)
[0087] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 3.677 1.046 1.000 0.664 0.568 2 3.669 1.047 1.000 0.664 0.568 3 3.673 1.047 1.000 0.664 0.568 4 3.659 1.047 1.000 0.664 0.568 5 3.671 1.061 1.000 0.664 0.568 6 3.668 1.046 1.000 0.665 0.569 Average 3.669 1.049 1.000 0.664 0.568 SD 0.006 0.006 0.000 0.000 0.000 RSD 0.166% 0.545% 0.000% 0.050% 0.060%
[0088] Table 4 Relative peak area RSD (repeatability study)
[0089] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 0.095 0.141 1.000 0.281 0.126 2 0.095 0.144 1.000 0.286 0.125 3 0.095 0.143 1.000 0.286 0.126 4 0.095 0.142 1.000 0.283 0.127 5 0.095 0.141 1.000 0.281 0.127 6 0.095 0.141 1.000 0.281 0.128 Average 0.095 0.142 1.000 0.283 0.126 SD 0.000 0.001 0.000 0.002 0.001 RSD 0.389% 0.740% 0.000% 0.883% 0.705%
[0090] 3. Stability verification
[0091] According to the sample preparation method and chromatographic conditions of Example 1, a test solution was prepared and analyzed at 0 h, 4 h, 8 h, 12 h, 18 h, and 24 h, respectively. Luteolin (peak 3) was used as the reference peak, and the relative retention time (Table 5) and relative peak area value (Table 6) of the characteristic peaks (peak 1: chlorogenic acid; peak 2: magnoside; peak 3: luteolin; peak 4: magnolin; peak 5: imperatorin) and the reference peaks were investigated.
[0092] The results showed that the RSD of the relative retention time of each characteristic peak was between 0.037% and 0.550%, and the RSD of the relative peak area was between 0.444% and 0.726%, indicating that the test solution had good stability within 24 hours.
[0093] Table 5 Relative retention time RSD (stability study)
[0094] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 0h 3.657 1.046 1.000 0.664 0.568 4h 3.668 1.046 1.000 0.664 0.569 8h 3.677 1.046 1.000 0.664 0.568 12h 3.671 1.061 1.000 0.664 0.568 18h 3.673 1.047 1.000 0.664 0.568 24h 3.653 1.047 1.000 0.664 0.567 Average 3.667 1.049 1.000 0.664 0.568 SD 0.009 0.006 0.000 0.000 0.000 RSD 0.252% 0.550% 0.000% 0.037% 0.081%
[0095] Table 6 Relative peak area RSD (stability study)
[0096] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 0h 0.093 0.136 1.000 0.256 0.117 4h 0.093 0.136 1.000 0.255 0.117 8h 0.093 0.136 1.000 0.256 0.117 12h 0.093 0.135 1.000 0.257 0.116 18h 0.093 0.135 1.000 0.256 0.117 24h 0.092 0.135 1.000 0.254 0.115 Average 0.093 0.136 1.000 0.256 0.117 SD 0.001 0.001 0.000 0.001 0.001 RSD 0.726% 0.458% 0.000% 0.444% 0.695%
[0097] 4. Through various verifications in this experiment, the HPLC fingerprint method established by the present invention is reliable.
[0098] Example 3 HPLC fingerprint quantitative detection
[0099] 1. Instrument precision
[0100] According to the sample preparation method and chromatographic conditions of Example 1, a sample solution was prepared and analyzed six times continuously. The results showed that the RSD of chlorogenic acid content was 0.888%, the RSD of montanol content was 0.682%, the RSD of luteolin content was 0.544%, the RSD of magnolin content was 0.304%, and the RSD of imperatorin content was 0.812%, and RSD was less than 3%, indicating that the instrument used had good precision in quantitative detection of the sample solution of the Chinese medicine preparation for the prevention and treatment of poultry infectious rhinitis.
[0101] Table 7 RSD (precision study) of chlorogenic acid, montmorillonin, luteolin, magnolin and imperatorin content
[0102] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 14.877 2.712 0.102 3.428 0.267 2 14.687 2.692 0.103 3.416 0.264 3 14.864 2.729 0.103 3.408 0.270 4 14.617 2.695 0.103 3.432 0.266 5 14.570 2.729 0.102 3.409 0.267 6 14.810 2.736 0.102 3.409 0.267 Average 14.737 2.716 0.102 3.417 0.267 SD 0.131 0.019 0.001 0.010 0.002 RSD 0.888% 0.682% 0.544% 0.304% 0.812%
[0103] 2. Repeatability
[0104] According to the preparation method and chromatographic conditions of Example 1, six test solutions were prepared for analysis. The results showed that the RSD of chlorogenic acid content was 0.481%, the RSD of montanol content was 0.286%, the RSD of luteolin content was 0.477%, the RSD of magnolin content was 0.319%, and the RSD of imperatorin content was 0.556%, and the RSD was less than 3%, indicating that the method has good repeatability for quantitative detection of test solution of Chinese medicine preparation for the prevention and treatment of poultry infectious rhinitis.
[0105] Table 8 RSD of chlorogenic acid, magnoside, luteolin, magnolin and imperatorin content (repeatability test)
[0106] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 1 14.977 2.752 0.102 3.428 0.271 2 14.964 2.759 0.103 3.408 0.270 3 14.910 2.766 0.102 3.409 0.271 4 15.089 2.770 0.103 3.428 0.272 5 15.082 2.763 0.102 2.434 0.274 6 15.047 2.775 0.102 3.428 0.273 Average 15.011 3.764 0.102 3.422 0.272 SD 0.072 0.008 0.000 0.011 0.002 RSD 0.481% 0.286% 0.477% 0.319% 0.556%
[0107] 3. Stability
[0108] According to the preparation method and chromatographic conditions of Example 1, a sample solution was prepared for analysis. The chromatographic analysis results of 0h, 4h, 8h, 12h, 18h, and 24h were counted respectively. The results showed that the RSD of chlorogenic acid content was 0.647%, the RSD of montanol content was 1.346%, the RSD of luteolin content was 1.181%, the RSD of magnolin content was 1.669%, and the RSD of imperatorin content was 1.245%, and RSD <3%, indicating that the content of the main index components of the sample solution of the Chinese medicine preparation for the prevention and treatment of poultry infectious rhinitis was stable within 24h.
[0109] Table 9 RSD of chlorogenic acid, magnoside, luteolin, magnolin and imperatorin content (stability study)
[0110] Sample No. Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 0h 15.087 2.772 0.108 3.498 0.274 4h 15.247 2.775 0.110 3.588 0.279 8h 15.182 2.763 0.109 3.534 0.274 12h 15.286 2.811 0.110 3.491 0.246 18h 15.226 2.861 0.107 3.588 0.279 24h 15.380 2.823 0.109 3.642 0.283 Average 15.235 2.801 0.109 3.557 0.278 SD 0.099 0.038 0.01 0.059 0.003 RSD 0.647% 1.346% 1.181% 1.669% 1.245%
[0111] Example 4 HPLC fingerprint detection of 10 batches of Chinese medicine preparations for preventing and treating poultry infectious rhinitis from the same manufacturer
[0112] Implementation Methods
[0113] The quantitative fingerprint spectrum method established in Example 3 was used to perform fingerprint analysis on 10 batches of Chinese medicine preparations for preventing and treating poultry infectious rhinitis from the same manufacturer, and the chromatograms were recorded. The chromatograms were imported into the Chinese medicine chromatographic fingerprint similarity evaluation system for chromatographic peak matching (Chinese medicine fingerprint similarity evaluation system 2012.0 version), see Figure 1 , see the reference map Figure 2 .
[0114] The similarity calculation results show that the similarities of 10 batches of Chinese herbal preparations for the prevention and treatment of poultry infectious rhinitis produced by the same manufacturer are all greater than 0.999, see Table 10.
[0115] Table 10 Similarity evaluation results of 10 batches of Chinese medicine preparations for the prevention and treatment of poultry infectious rhinitis from the same manufacturer
[0116] Serial number S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 Similarity 0.999 0.999 0.999 0.999 0.999 0.999 0.999 0.999 0.999 0.999
[0117] Example 5 Quantitative detection of 10 batches of Chinese medicine preparations with different contents for preventing and treating infectious rhinitis in poultry
[0118] Implementation Methods
[0119] The HPLC fingerprint quantitative detection method verified in Example 3 was used to conduct quantitative detection on 10 batches of Chinese medicine preparations for preventing and treating poultry infectious rhinitis with different contents. The quantitative detection results are shown in Table 11, and the characteristic peak retention times are shown in Table 12.
[0120] Table 11 Quantitative test results of 10 batches of Chinese medicine preparations with different contents for the prevention and treatment of infectious rhinitis in poultry
[0121]
[0122] Table 12 Retention time of characteristic peaks of 10 batches of Chinese medicine preparations with different contents for the prevention and treatment of infectious rhinitis in poultry
[0123]
[0124] The results showed that this method can be used to quantitatively detect the contents of effective ingredients in Chinese herbal medicines for the prevention and treatment of poultry infectious rhinitis.
[0125] Example 6 In vitro inflammation prevention test
[0126] 1. Implementation methods
[0127] 1) Preparation of sample solution
[0128] According to the amount of crude drugs in traditional Chinese medicine preparations for preventing and treating infectious rhinitis in poultry, a 1 mg / ml sample solution was prepared.
[0129] 2) Establishment of inflammation prevention model and drug administration scheme
[0130] RAW264.7 cells were cultured at 1×10 5 / mL density was inoculated in a 96-well plate and divided into groups after 24 hours. The drug-containing culture medium was discarded after 6 hours, and serum-free DMEM complete culture medium was added for culture. 2μg / mL LPS was added to the model group and the drug-treated group, and the cells were placed in a 5% CO2, 37℃ incubator for induction for 24 hours.
[0131] 3) Determination of various anti-inflammatory activity indicators
[0132] A) NO release test
[0133] After the administration, the cell supernatant was collected and the NO release in the administration group, blank group and model group was detected using the NO detection kit.
[0134] B) IL-6 level test
[0135] After the administration, the cell supernatant was collected and the IL-6 level changes in the administration group, blank group and model group were detected using the IL-6 detection kit.
[0136] C) TNF-α level test
[0137] After the administration, the cell supernatant was collected and the changes in TNF-α levels in the administration group, blank group and model group were detected using the TNF-α detection kit.
[0138] 2. Test results
[0139] 1) NO release measurement results
[0140] The test results showed that compared with the blank group, the release of NO in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the release of NO in each drug-treated group was significantly reduced, with a very significant difference, P < 0.01. The results are shown in Table 13.
[0141] Table 13 NO release measurement results
[0142]
[0143]
[0144] Note: Compared with the blank group, ** indicates a very significant difference (P<0.01); compared with the model group, ## Represents extremely significant difference (P<0.01). # Represents significant difference (0.01<P<0.05)
[0145] 2) IL-6 level measurement results
[0146] The test results showed that compared with the blank group, the IL-6 level in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the IL-6 level in each drug group was significantly reduced, and each drug administration group had a very significant difference, P < 0.01. The results are shown in Table 14.
[0147] Table 14 IL-6 level measurement results
[0148] Group IL-6 (pg / mL) Blank Group 28.81±1.11 LPS model group <![CDATA[52.62±0.74 ** ]]> S1 <![CDATA[42.22±0.29 ## ]]> S2 <![CDATA[46.52±0.16 ## ]]> S3 <![CDATA[42.77±1.47 ## ]]> S4 <![CDATA[42.84±0.78 ## ]]> S5 <![CDATA[41.35±0.96 ## ]]> S6 <![CDATA[45.49±0.50 ## ]]> S7 <![CDATA[44.20±0.33 ## ]]> S8 <![CDATA[42.54±0.77 ## ]]> S9 <![CDATA[43.48±0.33 ## ]]> S10 <![CDATA[43.46±1.25 ## ]]>
[0149] Note: Compared with the blank group, ** indicates a very significant difference (P<0.01); compared with the model group, ## Represents extremely significant difference (P<0.01). # Represents significant difference (0.01<P<0.05)
[0150] 3) TNF-α level measurement results
[0151] The results showed that compared with the blank group, the TNF-α level in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the TNF-α level in each drug-treated group decreased to varying degrees, with extremely significant differences in the S2-S4, S8, and S9 groups, P < 0.01; the other drug-treated groups had significant differences, 0.01 < P < 0.05.
[0152] Table 15 TNF-α level determination results
[0153]
[0154]
[0155] Note: Compared with the blank group, ** indicates a very significant difference (P<0.01); compared with the model group, ## Represents extremely significant difference (P<0.01). # Represents significant difference (0.01<P<0.05)
[0156] By measuring the NO release in the cell supernatant and the anti-inflammatory levels of IL-6 and TNF-α, the cellular inflammation model was successfully established in this example, and the differences between the blank group and the drug-treated group and the model group were statistically significant.
[0157] Example 7 In vitro direct anti-inflammatory test
[0158] 1. Implementation methods:
[0159] 1) Preparation of sample solution:
[0160] According to the amount of raw drugs in the traditional Chinese medicine preparation for the prevention and treatment of infectious rhinitis in chickens and poultry, a 1 mg / ml sample solution was prepared.
[0161] 2) Establishment of direct anti-inflammatory model and drug administration scheme
[0162] RAW264.7 cells in the logarithmic growth phase were cultured at 1×10 5 / mL density was inoculated in a 96-well plate and divided into groups after 24 hours. The blank group was cultured with serum-free DMEM complete medium, the model group was added with 2μg / mL LPS, and the drug-treated group was added with 2μg / mL LPS and 1.0mg / ml of 10 batches of sample solutions at the same time, and placed in a 5% CO2, 37℃ incubator for induction for 24 hours.
[0163] 3) Determination of various anti-inflammatory indicators
[0164] A) NO release test
[0165] After the administration, the cell supernatant was collected and the NO release in the administration group, blank group and model group was detected using the NO detection kit.
[0166] B) IL-6 level test
[0167] After the administration, the cell supernatant was collected and the IL-6 level changes in the administration group, blank group and model group were detected using the IL-6 detection kit.
[0168] C) TNF-α level test
[0169] After the administration, the cell supernatant was collected and the changes in TNF-α levels in the administration group, blank group and model group were detected using the TNF-α detection kit.
[0170] 2. Test results
[0171] 1) NO release measurement results
[0172] The results showed that compared with the blank group, the release of NO in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the release of NO in each drug-treated group decreased to varying degrees, with S1-S6, S8, and S10 groups having very significant differences, P < 0.01; S7 and S9 groups having significant differences, 0.01 < P < 0.05. The results are shown in 16.
[0173] Table 16 NO release measurement results
[0174] Group NO(μmol / mL) Blank Group 5.90±0.15 LPS model group <![CDATA[32.48±2.02 ** ]]> S1 <![CDATA[21.60±0.20 ## ]]> S2 <![CDATA[22.53±0.25 ## ]]> S3 <![CDATA[26.37±0.61 ## ]]> S4 <![CDATA[26.64±0.11 ## ]]> S5 <![CDATA[24.61±0.15 ## ]]> S6 <![CDATA[27.23±0.45 ## ]]> S7 <![CDATA[29.32±0.16 # ]]> S8 <![CDATA[27.40±0.80 ## ]]> S9 <![CDATA[29.37±0.82 # ]]> S10 <![CDATA[27.01±0.59 ## ]]>
[0175] Note: Compared with the blank group, ** indicates a very significant difference (P<0.01); compared with the model group, ## The difference is extremely significant (P<0.01)
[0176] 2) IL-6 level measurement results
[0177] The test results showed that compared with the blank group, the IL-6 level in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the IL-6 level in each drug administration group was significantly reduced, and each drug administration group had a very significant difference, P < 0.01. The results are shown in Table 17.
[0178] Table 17 IL-6 level measurement results
[0179] Group IL-6 (pg / mL) Blank Group 35.45±0.45 LPS model group <![CDATA[51.49±2.10 ** ]]> S1 <![CDATA[32.50±0.63 ## ]]> S2 <![CDATA[30.95±0.85 ## ]]> S3 <![CDATA[40.45±0.23 ## ]]> S4 <![CDATA[35.14±1.35 ## ]]> S5 <![CDATA[33.25±0.30 ## ]]> S6 <![CDATA[38.79±1.35 ## ]]> S7 <![CDATA[35.46±0.58 ## ]]> S8 <![CDATA[34.23±1.55 ## ]]> S9 <![CDATA[38.20±0.77 ## ]]> S10 <![CDATA[37.62±1.15 ## ]]>
[0180] Note: Compared with the blank group,** indicates a very significant difference (P<0.01); compared with the model group, ## Represents extremely significant difference (P<0.01). # Represents significant difference (0.01<P<0.05)
[0181] 3) TNF-α level measurement results
[0182] The test results showed that compared with the blank group, the TNF-α level in the cell supernatant of RAW264.7 cells induced by LPS was significantly increased, with a very significant difference, P < 0.01, indicating that the model was successfully established. Compared with the LPS model group, the TNF-α level in each drug-treated group was significantly reduced, with a very significant difference, P < 0.01. The results are shown in Table 18.
[0183] Table 18 TNF-α level determination results
[0184] Group TNF-α(pg / mL) Blank Group 146.67±0.53 LPS model group <![CDATA[254.37±0.75 ** ]]> S1 <![CDATA[176.87±0.40 ## ]]> S2 <![CDATA[165.48±0.79 ## ]]> S3 <![CDATA[181.54±0.41 ## ]]> S4 <![CDATA[168.80±0.44 ## ]]> S5 <![CDATA[175.48±1.24 ## ]]> S6 <![CDATA[163.86±0.61 ## ]]> S7 <![CDATA[189.92±0.95 ## ]]> S8 <![CDATA[179.54±0.25 ## ]]> S9 <![CDATA[174.34±0.45 ## ]]> S10 <![CDATA[176.74±1.15 ## ]]>
[0185] Note: Compared with the blank group, ** indicates a very significant difference (P<0.01); compared with the model group, ## Represents extremely significant difference (P<0.01). # Represents significant difference (0.01<P<0.05)
[0186] By measuring the NO release in the cell supernatant and the anti-inflammatory levels of IL-6 and TNF-α, the cellular inflammation model was successfully established in this example, and the differences between the blank group and the drug-treated group and the model group were statistically significant.
[0187] Example 8 Spectrum-effect relationship analysis
[0188] This example uses the grey correlation analysis method to reveal the relationship between multiple independent variables and a dependent variable, and the magnitude of the correlation is used to determine the magnitude of the influence of the variable on the index. The dimensionless results of the characteristic peak area are shown in Table 19, and the dimensionless results of the anti-inflammatory activity are shown in Table 20.
[0189] Table 19 Dimensionless processing results of characteristic peak areas of fingerprint spectra of 10 batches of samples
[0190]
[0191]
[0192] Table 20 Dimensionless processing results of anti-inflammatory activity of 10 batches of samples
[0193]
[0194] 1. Implementation methods
[0195] (1) Grey correlation analysis
[0196] The basic steps of grey relational analysis include:
[0197] 1) The anti-inflammatory activity index of each sample is used to form a reference series, and the peak area of the characteristic peaks in the fingerprint of each sample is used to form a comparison series;
[0198] 2) Dimensionless processing is performed on the reference series and the comparison series; the averaging method is used for processing;
[0199] 3) Calculate the correlation between each characteristic peak and anti-inflammatory activity based on the dimensionless reference series and comparison series;
[0200] 4) Sort the association degrees obtained in step 3).
[0201] In the process of calculating the correlation, the correlation coefficient can be calculated according to the following formula:
[0202]
[0203] Among them, x0(k) represents the reference series, xi(k) represents the comparison series, and ρ is the resolution coefficient, which is usually 0.5.
[0204] Then calculate the correlation according to the following formula:
[0205]
[0206] The averaging method generally refers to dividing each variable value by the average value of the variable. This method eliminates the influence of dimension and order of magnitude while retaining the information on the degree of difference of individual variable values and the comparability of data.
[0207] 2. Test results
[0208] 1) Prevention of inflammation test
[0209] A) NO release
[0210] Grey relational analysis
[0211] From Table 21, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of NO release is ranked as follows: mongoside> imperatorin> magnolin> chlorogenic acid> luteolin
[0212] Among them, the correlation between limonene glycoside and the reduction of NO release is the greatest, suggesting that limonene glycoside is most closely related to the reduction of NO release.
[0213] The peaks corresponding to the correlation degree greater than 0.7 (imperatorin and magnolin) also play a certain synergistic role in reducing the release of NO.
[0214] Table 21 Grey correlation analysis results of reducing NO release
[0215] Chromatographic peak tR / min Relevance Chlorogenic acid 20.966 0.6996 Ligusticum glabra 73.288 0.7249 Luteolin 76.679 0.6749 Magnoliaceae 115.418 0.7105 Imperatorin 134.881 0.7158
[0216] B) IL-6 levels
[0217] Grey relational analysis
[0218] From Table 22, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of IL-6 levels is ranked as follows: mongoside> imperatorin> magnolin> luteolin> chlorogenic acid
[0219] Among them, the correlation between limonene glycoside and the reduction of IL-6 levels was the greatest, indicating that limonene glycoside was most closely related to the reduction of IL-6 levels.
[0220] The peak corresponding to the correlation degree greater than 0.7 (imperatorin) also plays a certain synergistic role in reducing IL-6 levels.
[0221] Table 22 Results of correlation analysis on reducing IL-6 levels
[0222] Chromatographic peak tR / min Relevance Chlorogenic acid 20.947 0.6252 Ligusticum glabra 73.233 0.7087 Luteolin 76.612 0.6835 Magnoliaceae 115.370 0.6849 Imperatorin 134.879 0.7009
[0223] C) TNF-α levels
[0224] Grey relational analysis
[0225] From Table 23, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of TNF-α levels is ranked as follows: imperatorin > montanol > magnolin > chlorogenic acid > luteolin
[0226] Among them, the correlation between imperatorin and the reduction of TNF-α levels was the greatest, suggesting that imperatorin was most closely related to the reduction of TNF-α levels.
[0227] The peaks corresponding to the correlation degree greater than 0.7 (monganin and magnolia glycosides) also play a certain synergistic role in reducing TNF-α levels.
[0228] Table 23 Results of correlation analysis on reducing TNF-α levels
[0229] Chromatographic peak tR / min Relevance Chlorogenic acid 20.908 0.6710 Ligusticum glabra 73.294 0.7459 Luteolin 76.691 0.6364 Magnoliaceae 115.453 0.7031 Imperatorin 134.856 0.7796
[0230] 2) Direct anti-inflammatory test
[0231] A) NO release
[0232] Grey relational analysis
[0233] From Table 24, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of NO release is ranked as follows: chlorogenic acid > montanol > magnolin > imperatorin > luteolin
[0234] Among them, the correlation between chlorogenic acid and the reduction of NO release is the greatest, suggesting that chlorogenic acid is most closely related to the reduction of NO release.
[0235] The peaks corresponding to the correlation degree greater than 0.7 (monogatrin and magnolia glycosides) also play a certain synergistic role in reducing the release of NO.
[0236] Table 24 Grey correlation analysis results of reducing NO release
[0237] Chromatographic peak tR / min Relevance Chlorogenic acid 20.934 0.7149 Ligusticum glabra 73.046 0.7107 Luteolin 76.478 0.6726 Magnoliaceae 115.218 0.7016 Imperatorin 134.768 0.6970
[0238] B) IL-6 levels
[0239] Grey relational analysis
[0240] From Table 25, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of IL-6 levels is ranked as follows: chlorogenic acid > montanol > magnolin > imperatorin > luteolin
[0241] Among them, the correlation between chlorogenic acid and lowering IL-6 levels was the greatest, suggesting that chlorogenic acid was most closely related to lowering IL-6 levels.
[0242] Table 25 Results of correlation analysis on reducing IL-6 levels
[0243] Chromatographic peak tR / min Relevance Chlorogenic acid 20.879 0.7325 Ligusticum glabra 73.267 0.6872 Luteolin 76.652 0.6530 Magnoliaceae 115.408 0.6862 Imperatorin 134.864 0.6724
[0244] C) TNF-α levels
[0245] Grey relational analysis
[0246] From Table 26, it can be seen that the correlation between the chemical substances represented by each variable and the reduction of TNF-α levels is ranked as follows: mongoside>chlorogenic acid>imperatorin>magnolin>luteolin
[0247] Among them, the correlation between limonene glycoside and the reduction of TNF-α levels was the greatest, indicating that limonene glycoside was most closely related to the reduction of TNF-α levels.
[0248] The peaks corresponding to the correlation degree greater than 0.7 (chlorogenic acid and imperatorin) also play a certain synergistic role in reducing TNF-α.
[0249] Table 26 Results of correlation analysis on reducing TNF-α levels
[0250] Chromatographic peak tR / min Relevance Chlorogenic acid 20.841 0.7030 Ligusticum glabra 73.225 0.7522 Luteolin 76.625 0.6724 Magnoliaceae 115.419 0.6787 Imperatorin 134.910 0.7019
Claims
1. A method for detecting fingerprints of Chinese medicinal preparations for preventing and treating poultry infectious rhinitis, characterized in that: The fingerprint detection method is to use HPLC detection method to simultaneously detect the contents of chlorogenic acid, magnoside, luteolin, magnolin and imperatorin; the detection steps are as follows: (1) preparation of reference solution; (2) preparation of test solution; (3) analysis by high performance liquid phase HPLC chromatography-ultraviolet detection; (4) extraction of characteristic chromatographic peaks and establishment of fingerprint spectrum; The HPLC chromatographic conditions in step (3) are as follows: the chromatographic column is Supfex JX-C18, 5 μm, 4.6×250 mm; pure acetonitrile is used as mobile phase A, 0.1% formic acid / water is used as mobile phase B, and gradient elution is performed. The elution conditions are: 0-35 min, 8%-15% A; 35-75 min, 15%-30% A; 75-110 min, 30%-40% A; 110-150 min, 40%-60% A; 150-155 min, 60%-40% A; The preparation method of the test solution in step (2) is as follows: accurately weigh the Chinese medicine preparation for preventing and treating poultry infectious rhinitis, add 50% methanol / water solution, weigh, sonicate, cool to room temperature, weigh again, make up for the loss, filter, and obtain; The Chinese medicinal components in the Chinese medicinal preparation consist of fried Xanthium sibiricum fruit, Plantago asiatica, Magnolia officinalis, Angelica dahurica and Buddleja buddleja.
2. The detection method according to claim 1, characterized in that: HPLC detection conditions are: column temperature, 30°C; flow rate, 1.0 ml / min; detection wavelength, 250 nm.
3. The detection method according to claim 1, characterized in that: The preparation method of the reference substance solution in step (1) is to weigh chlorogenic acid, magnoside, luteolin, magnolin and imperatorin reference substances respectively, dilute them with methanol to prepare stock solutions; and mix the stock solutions to prepare the reference substance solution.
4. The detection method according to claim 3, characterized in that: In each of the stock solutions described in step (1), the chlorogenic acid content in the chlorogenic acid stock solution is 500 μg / ml, the content of montana glycoside in the montana glycoside stock solution is 1000 μg / ml, the content of luteolin in the luteolin stock solution is 1000 μg / ml, the content of magnolia glycoside in the magnolia glycoside stock solution is 1000 μg / ml, and the content of imperatorin in the imperatorin stock solution is 100 μg / ml; the concentration of chlorogenic acid in the reference solution is 50 μg / ml, the concentration of montana glycoside is 100 μg / ml, the concentration of luteolin is 100 μg / ml, the concentration of magnolia glycoside is 100 μg / ml, and the concentration of imperatorin is 10 μg / ml.
5. The detection method according to claim 1, characterized in that: The characteristic chromatographic peaks described in step (4) are chlorogenic acid, limonene, luteolin, magnolia and imperatorin respectively; the retention times of the characteristic peaks are: chlorogenic acid 20.843-20.966 min, limonene 73.046-73.294 min, luteolin 76.478-76.691 min, magnolia 115.218-115.453 min, imperatorin 134.786-134.910 min.
6. A quality detection method for a Chinese medicine preparation for preventing and treating poultry infectious rhinitis based on spectrum-effect relationship, characterized in that: The following steps are involved: (1) establishing an HPLC fingerprint detection method for a Chinese herbal medicine preparation for preventing and treating infectious rhinitis in poultry according to any one of claims 1 to 5; (2) determining the anti-inflammatory activity of the Chinese herbal medicine preparation for preventing and treating infectious rhinitis in poultry; (3) performing a grey correlation analysis on the peak area of the characteristic peak identified in step (1) and the anti-inflammatory activity obtained in step (2), calculating the correlation between each characteristic peak and the anti-inflammatory activity, and evaluating the anti-inflammatory activity of the characteristic peak.
7. The detection method according to claim 6, characterized in that: The test for determining the anti-inflammatory activity of the Chinese herbal preparation for preventing and treating infectious rhinitis in poultry in step (2) is divided into an inflammation prevention test and a direct anti-inflammatory test; the inflammation prevention test is as follows: RAW264.7 cells are placed in close contact with a 96-well plate, and after 24 hours, a sample solution of the Chinese herbal preparation for preventing and treating infectious rhinitis in poultry is added to the cells for culture, and after 6 hours of culture, the drug-containing culture medium is discarded, and LPS is added to induce cell inflammation, and after 24 hours of induction, the NO release amount and the IL-6 and TNF-α levels in the cell supernatant are determined; the direct anti-inflammatory test is as follows: RAW264.7 cells are placed in close contact with a 96-well plate, and after 24 hours, LPS is added to induce cell inflammation, and at the same time, a sample solution of the Chinese herbal preparation for preventing and treating infectious rhinitis in poultry is added to the cells, and after 24 hours of action, the NO release amount and the IL-6 and TNF-α levels in the cell supernatant are determined.
8. The detection method according to claim 6, characterized in that: The grey relational analysis steps are as follows: (1) The anti-inflammatory activity index of each sample is composed into a reference series, and the peak area of each characteristic peak in the fingerprint spectrum of each sample is composed into a comparison series; (2) The reference series and the comparison series described in step (1) are dimensionlessly processed by homogenization method; (3) calculating the correlation between each characteristic peak and the anti-inflammatory activity based on the dimensionless reference series and comparison series obtained in step (2); (4) Sort the correlation degrees obtained in step (3) and evaluate the anti-inflammatory activity of the characteristic peaks.
